Disulfide bond reduction and exchange in C4 domain of von Willebrand factor undermines platelet binding. 2023

Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
Heidelberg Institute for Theoretical Studies, Schloß-Wolfsbrunnenweg 35, Heidelberg, Germany.

The von Willebrand factor (VWF) is a key player in regulating hemostasis through adhesion of platelets to sites of vascular injury. It is a large, multi-domain, mechano-sensitive protein that is stabilized by a net of disulfide bridges. Binding to platelet integrin is achieved by the VWF-C4 domain, which exhibits a fixed fold, even under conditions of severe mechanical stress, but only if critical internal disulfide bonds are closed. To determine the oxidation state of disulfide bridges in the C4 domain of VWF and implications for VWF's platelet binding function. We combined classical molecular dynamics and quantum mechanical simulations, mass spectrometry, site-directed mutagenesis, and platelet binding assays. We show that 2 disulfide bonds in the VWF-C4 domain, namely the 2 major force-bearing ones, are partially reduced in human blood. Reduction leads to pronounced conformational changes within C4 that considerably affect the accessibility of the integrin-binding motif, and thereby impair integrin-mediated platelet binding. We also reveal that reduced species in the C4 domain undergo specific thiol/disulfide exchanges with the remaining disulfide bridges, in a process in which mechanical force may increase the proximity of specific reactant cysteines, further trapping C4 in a state of low integrin-binding propensity. We identify a multitude of redox states in all 6 VWF-C domains, suggesting disulfide bond reduction and swapping to be a general theme. Our data suggests a mechanism in which disulfide bonds dynamically swap cysteine partners and control the interaction of VWF with integrin and potentially other partners, thereby critically influencing its hemostatic function.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D004220 Disulfides Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties. Disulfide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072417 Protein Domains Discrete protein structural units that may fold independently of the rest of the protein and have their own functions. Peptide Domain,Protein Domain,Domain, Peptide,Domain, Protein,Domains, Peptide,Domains, Protein,Peptide Domains
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor
D016023 Integrins A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation. Integrin

Related Publications

Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
February 1993, The Journal of biological chemistry,
Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
January 2019, Blood,
Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
December 2010, Journal of thrombosis and haemostasis : JTH,
Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
July 1987, The Journal of laboratory and clinical medicine,
Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
March 1986, The Journal of clinical investigation,
Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
February 2022, Thrombosis and haemostasis,
Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
June 1978, Thrombosis and haemostasis,
Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
February 2018, Science advances,
Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
March 2021, Blood,
Fabian Kutzki, and Diego Butera, and Angelina J Lay, and Denis Maag, and Joyce Chiu, and Heng-Giap Woon, and Tomáš Kubař, and Marcus Elstner, and Camilo Aponte-Santamaría, and Philip J Hogg, and Frauke Gräter
June 1991, Mayo Clinic proceedings,
Copied contents to your clipboard!